Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden hearing aid? new implant could restore speech without visible parts

NCT ID NCT06459765

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new type of cochlear implant that is completely hidden under the skin, with no external parts. Thirty adults with severe hearing loss received the implant to see if it improved their ability to understand speech. Participants took word and sentence tests, hearing checks, and quality-of-life surveys before and after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mi2000 totally implantable cochlear implant (device)
What this could lead to
If successful, this device could provide a fully hidden cochlear implant that improves speech understanding in quiet and noise, offering a more discreet and convenient option for people with severe hearing loss.
What could go wrong
This is a small, completed study with only 30 participants, so results may not apply to everyone. The device is new and may have unknown risks or technical issues, and long-term benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Minimum age of eighteen (18) years at time of enrolment * Bilateral sensorineural hearing loss with no or limited benefit from a hearing aid (\>70 dB HL PTA4) * Post-lingual onset of deafness * No or limited benefit from hearing aids for less than 10 years and an expected benefit from cochlear implantation * A maximum score of 50% on a word test in the language of the test centre in the ear to be implanted in the best aided condition * Fluency in the test language with excellent proficiency, as appropriate to perform speech testing * Functional auditory nerve * General health condition, psychological and emotional condition deemed compatible with the treatment and tests performed in this study * Pre-operative assessment according to the local professional standards * Candidate is highly motivated and has realistic expectations about the expected benefit of the implant and shall understand the importance of returning to the implant centre for regular speech processor programming, assessment sessions and training * Realistic expectations, as deemed appropriate by the implanting surgeon/implant board * Evidence of up-to-date vaccinations against meningitis, as per recommendations by the applicable national body * Signed and dated informed consent before the start of any study-specific procedure Exclusion Criteria: * Lack of compliance with any inclusion criterion * Previously having received an implant on the location chosen for placing the cochlear implant * Having received a hearing implant from another manufacturer than MED-EL on the contralateral ear * Pre-existing condition known to necessitate MRI scans after implantation of the Mi2000 TICI * Women being pregnant or nursing * Women of childbearing age not reporting to use effective contraception * The individual is known to be intolerant of the materials used in the implant or other required accessories including medical grade silicone, parylene C, titanium, platinum iridium, platinum, stainless chromate steel, thermoplastic elastomere (TPE-S), thermoplastic elastomere (SEBS), mixture of polycarbonate and acrylonitrile-butadiene-styrol polymer (PC/ABS), polyamide, liquid crystal polymer, silicone and polyurethane-coated silicone rubber) * Absence of cochlear development * The cause of deafness is non-functionality of the auditory nerve and/or the upper auditory pathway * Medical contra-indications to middle ear and/or inner ear surgery, and/or anaesthesia * External or middle ear infections are present * The tympanic membrane is perforated in the ear to be implanted * Anatomic abnormalities are present that would prevent appropriate placement of the stimulator housing in the bone of the skull, or prevent placement of the chosen electrode array into the cochlea (including ossification of the cochlea) * The psychological status of the individual is unstable * The individual has unrealistic expectations * Acute cholesteatoma * History of vestibular schwannoma * Unstable Meniere's disease * Auditory Neuropathy * Epilepsy not responding to treatment * Permanent inability and/or unwillingness to participation in post-operative care and rehabilitation * Known intellectual disability and/or psychological diseases * Participation in other pharmacological clinical trials within four weeks prior to enrolment * Anything that, in the opinion of the Investigator, would place the subject at increased risk; preclude the subject's full compliance with or completion of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, sensorineural are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AKH Wien

    Vienna, 1090, Austria

  • CHU Liège

    Liège, 4000, Belgium

  • LMU Munich

    München, Bavaria, 81377, Germany

  • The Institute of Physiology and Pathology of Hearing

    Nadarzyn, 05-830, Poland

  • UKW Würzburg

    Würzburg, Bavaria, 97080, Germany

  • UZA Antwerpen

    Antwerp, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.